Dec 01, 2022 01:36 PM (GMT+8) · EqualOcean
Digital Therapeutics (DTx) Developer NansTech (Chinese: 南粟科技) announced that it had completed a Series A funding round worth more than tens of millions of CNY, which was led by Shulan Junjie Captial (Chinese:树兰俊杰资本). This financing will be mainly used to promote the industrialization of DTx in brain disorder and medical devices registration, accelerate the R&D in DTx technology and brain function-related products, and achieve the clinical product promotion in the domestic market. In November 2022, NansTech won the first qualification of certified DTx in language disorder, making it the first enterprise with this leading technology and admission to the medical device market.